129 related articles for article (PubMed ID: 5082494)
1. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
2. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
3. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
4. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
5. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
6. The treatment of leprosy and its acute complications.
Jopling WH
Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
[No Abstract] [Full Text] [Related]
7. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
8. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
9. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
10. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
11. Management of neuritis in leprosy.
Pfaltzgraff RE
Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
[No Abstract] [Full Text] [Related]
12. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
13. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
14. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
15. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
16. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
[TBL] [Abstract][Full Text] [Related]
17. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
18. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
19. A survey of the drugs with activity against M. leprae in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
[No Abstract] [Full Text] [Related]
20. Clofazimine in leprosy.
Browne SG
Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304
[No Abstract] [Full Text] [Related]
[Next] [New Search]